Skip to main content

Table 6 Association of SOAT1 expression with the characteristic of HCC patients

From: Impacts of the SOAT1 genetic variants and protein expression on HBV-related hepatocellular carcinoma

  Low expression High expression P value OR CI (95%)
rs10753191
 CC 8 9 Ref. 1  
 CT 8 9 1 1 0.260–3.845
 TT 3 5 1 1.481 0.265–8.267
 Dominant model    1 1.131 0.328–3.898
 Recessive model    0.709 0.675 0.139–3.283
rs13306731
 AA 9 9 Ref. 1  
 AG 7 11 1 1 0.158–6346
 GG 3 3 0.738 1.571 0.418–5.903
 Dominant model    0.756 0.714 0.209–2.443
 Recessive model    1 0.800 0.142–4.513
Haplotype
 CCA 24 (63.16%) 27 (58.70%) Ref. /  
 TGA 1 (2.63%) 2 (4.35%) 1 1.778 0.151–20.863
 TGG 13 (34.21%) 17 (36.96%) 0.819 1.162 0.469–2.881
Stage
 0-B 12 15 Ref. /  
 C-D 7 8 1 1.094 0.308–3.883
  1. Fisher exact test